Dr. Nigel Haroon

Dr. Nigil Haroon, MD, PhD, is the Head of the Division of Rheumatology at Sinai Health and the University Health Network as well as the President of the Canadian Rheumatology Association. He is an associate professor of medicine and rheumatology at the University of Toronto and a Senior Scientist at the Krembil Research Institute and the Schroeder Arthritis Institute, a state of the art research facility in Toronto.

Dr. Haroon is an internationally renowned clinician scientist in the field of Ankylosing Spondylitis (AS). Dr. Haroon has a well-established translational research program at the University Health Network, Toronto and is known for his work in functional genomics of AS. He has published paradigm-shifting studies in AS including the first study to show that spinal progression in AS could be reduced with the use of TNF inhibitors. He identified the role for MIF, an innate immune molecule that can drive both inflammation and bone formation in AS patients.